Acute eosinophilic pneumonia associated with acute respiratory distress syndrome: Case report;Pneumonia eosinofílica aguda com evolução para síndroma de dificuldade respiratória aguda: Caso clí nico

Revista Portuguesa de Pneumologia

Volumn 10, Issue 4, 2004, Pages 355-364

  Baptista, J P F ^a   Casanova, P C ^a   Sousa, J P A ^b   Martins, P J ^b   Simoes A ^b   Fernandes, V ^b   Souto, J ^b   Costa, J J ^c   Rebelo, A ^c   Carvalho, L ^d   Pimentel, J ^c  

^a Hospitalar de Medicina Intensiva   (Portugal)

^b Hospitalar Grad de Med Intensiva

^c Serviço de Medicina Intensiva

^d Departamento de Anatomia Patologica

Author keywords

Acute eosinophilic pneumonia; Acute respiratory distress syndrome; Bronchoalveolar lavage fluid; Comunity adquired pneumonia; Eosinophilic pneumonia; Iatrogeny; Nitrofurantoin

Indexed keywords

CORTICOSTEROID; METHYLPREDNISOLONE; NITROFURANTOIN;

ADOLESCENT; ARTICLE; CASE REPORT; COMMUNITY ACQUIRED PNEUMONIA; CORTICOSTEROID THERAPY; DIFFERENTIAL DIAGNOSIS; EARLY DIAGNOSIS; HUMAN; LOEFFLER PNEUMONIA; LUNG LAVAGE; MALE; RESPIRATORY DISTRESS SYNDROME;

EID: 4844227063     PISSN: 08732159     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0873-2159(15)30590-0     Document Type: Article

References (41)

1. ALLEN JN, DAVIS WB. State of the art: the eosinophilic lung diseases. Am J Respir Crit Care Med 1994 150: 1423-38.
2. ALLEN JN, PACHT ER, GADEK JE, DAVIS WB. AEP as a reversible cause of noninfectious respiratory failure. N Engl J Med 1989. 321: 569-74.
3. BADESH DB, KING TE, SCHWARZ MI. AEP: A hypersensitivity phenomenom? Am Rev Respi Dis 1989. 139: 249-52.
4. BUDDHARAJU VL, SARACENO JL, ROSEN JM, SPIVACK SD, SMITH TC, ILVES R, KILLAM DA. AEP associated with shock. Crit Care Med 1999. 27:2014-16.
5. MEDURI GU, CHASTRE J. The standardization of bronchoscopic techniques for ventilator associated pneumonia. Chest 1992. 102,5,557S.
6. UMEKI S. Reevaluation of eosinophilic pneumonia and its diagnostic significance. Arch Int Med 1992;152:1913-9.
7. GROOTENDORST DC, SONT JK, WILLEMS LN, KLUIN-NELEMANS JC, VAN KRIEKEN JH, VESELIC-CHARVAT M, STERK PJ. Comparison of inflammatory cell counts in asthma: induced sputum vs bronchoalveolar lavage and bronchial biopsies. Clin Exp Allergy 1997 Jul;27(7):769-79.
8. REYNOLDS HY. Bronchoalveolar lavage. Am Rev Respir Dis 1987 Jan;135(1):250-63.
9. ALLEN JN , DAVIS JB, PACHT ER. Diagnostic significance of increased BAL fluid eosinophils. Am Rev Respir Dis 1990;142:642-7.
10. TOMASHEFSKY JF. Pulmonary pathology of ARDS in Clinics in Chest Medicine: ARDS 2000; 21:3435-90.
11. ROM WN, WEIDEN M, GARCIA R, YIE TA, VATHESATOGKIT P, TSE DB, MCGUINESS G, ROGGLI V, PREZANT D. AEP in a New York City fire-fighter exposed to World Trade Center dust. Am J Resp Crit Care Med 2002 15; 166(6):785-6.
12. WATANABE K, FUJIMURA N, KASAHARA K, YASUI M, MYOU S, KITA T, WATANABE A, NAKAO S. AEP following cigarrette smoking challenge test. Intern Med 2002 41(11): 1016-20.
13. TALMADGE EK: Idiopathic AEP. 2001; www.uptodate.com.
14. WENG T, YUAN A, TSAI KC, CHEN WJ. A patient with ARDS present initially with peripheral infiltration on chest radiographs and pulmonary eosinophilia, Am J Emerg Med 2001 Sep: 19(5): 457-8.
15. GIACOPPE GN, DEGLER DA. Rapid evolving ARDS with eosinophilia of unknow cause in previously healthy active duty soldiers at an army training center: report of two cases. Mil Med 1999 Dec; 164(12):911-6.
16. ALP H, DAUM RS, ABRAHAMS C, WYLAM ME. AEP: a cause of reversible, severe, noninfectious respiratory failure. J Pediatr 1998;132:540-3.
17. POPE HARMAN AL, DAVIS W, ALLEN ED, CHRISTOFORIDIS AJ, ALLEN JN. AEP: a summary of 15 cases and review of the literature. Medicine (Baltimore) Vol 75(6). November 1996;334-42.
18. MIYAZAKI E, KATSUNORI S, SHIGENAGA T, MATSUMOTO T, KITA S, INOBE Y, TSUDA T. A case of AEP caused by inalation of trichosporon terrestre. Am J Crit Care Med 1995. 151:541-3.
19. ISRAEL HJ, DIAMOND P. Recurrent pulmonary infiltration and pleural effusion due to nitrofurantoín sensivity. N Engl J Med 1962. 266:1024-26.
20. LIUBOV BN: Drug-induced respiratory disorders. Drug Safety 2000; 23(2):143-64.
21. CHUDNOFSKY CR, OTTEN EJ: Acute pulmonar toxicity to nitrofurantoin. The Journal of Emergency Medicine 1989;7:15-9.
22. MULBERG AE, BELL LM: Fatal cholestatic hepatitis and multisystem failure associated with nitrofurantoin. J Pediatr Gastroenterol Nutr 1993; 17(3):307-9.
23. ISRAEL RH, GROSS RA, BOMBA PA: ARDS associated with acute nitrofurantoin toxicity. Respiration 1980; 39(6):318-22.
24. NAGARATNAM N, RAJIYAH S, CHETIYAWARDEN AD: Acute respiratory distress following nitrofurantoin therapy. Ceylon Med J 1976; 21(2): 144-5.
25. MURRAY MJ, KRONENBERG R: Pulmonary reactions simulating cardiac pulmonary edema caused by nitrofurantoin. N Engl J Med 1965; 273:1185-87.
26. ODDO M, LIAUDET L, LEPORTY M, BROCCARD A, SCHALLER M: Relapsing acute respiratory failure induced by minocline. Chest 2003. 123:2146-8.
27. VALKE Y, PAUWELS R, STAETEN V: BAL in acute hipersensitivity pneumonitis caused by sulfasalazine. Chest 1987; 92: 572-3.
28. SEEBACH J, SPEICH R, FHER J, TUCHMIDT P, RUSSI E: GM-CSF induced AEP. Br J Hematol 1995; 90:963-5.
29. SALERNO SM, STRONG JS, ROTH BJ, SAKATA V: Eosinophilic pneumonia and respiratory failure associated with a trazodone overdose. Am J Respir Crit Care Med 1995;152:2170-2.
30. MARTINEZ BM, DOMINGO P: Eosinophilic pneumonia associated with tenidap. B Med J 1997; 314:349.
31. BARNES MT, BASCUNANA J, GARCIA B, ALVAREZ-SALA JL: AEP associated with antidepressant agents. Pharm World Sci 1999;21(5):241-2.
32. COETMUER D, GUIVARCH G, BRIENS E, LOPES C: PEA: rôle possible de la chloroquine. Rev Mal Respir 1998 15:657-60.
33. KELLY KJ, RUFFING R: AEP following intentional inalation of scotchguard. Ann Allergy 1993; 71:358-61.
34. OH PI, BALTER MS: Cocaine induced eosinophil lung disease. Thorax 1992; 47:478-79.
35. BOGESS KA, BENEDETTI TJ, RAGHU G: Nitrofuranton-induced pulmonary toxicity during pregnancy: a report of a case and review of the literature. Obstetrical and Gynecology Survey 1996; 51(6):367-70.
36. HOLMBERG L, BMAN G: Pulmonary reactions to nitrofurantoin - 447 cases reported to the Swedish Adverse Drug Reaction Committee 1966-1976. Eur J Respir Dis 1981; 62:180-9.
37. MAGEE F, WRIGHT JL, CHAN N, CURRIE W, KARR G, HOGG J, THURLBECK: Two unusual pathological reactions to nitrofurantoin: case reports. Histopathology 1986; 10:701-6.
38. MEYER MM, MEYER RJ: Nitrofurantoin-induced pulmonary hemorrage in a renal transplant recipient receiving imunosupressive therapy: case report and review of the literature. The Journal of Urology 1994; 152 (938-940).
39. BRUTINE LWM, MARTIN WJ: Chronic nitrofurantoín reactions reaction associated with T-lymphocyte alveolitis. Chest 1986;89:150.
40. CARBONERA D, ANGRILLI A, AZZONE GF: Mechanism of nitrofurantoín toxicity and oxidative stress in mitochondria. Biochim Biophys Acta 1988; 936:139.
41. MARTIN WJ: Nitrofurantoín: evidence for the oxidant injury of lung parenchymal cells. Am Rev Respir Dis 1983;127:482.